FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Clinical trial NCT07216105 · RECRUITING

Trial details

NCT number: NCT07216105
Sponsor: Fate Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Colorectal Cancer Breast Cancer Ovarian Cancer Endometrial Carcinoma Head and Neck Squamous Cell Carcinoma

Start date: 2025-11-04
Primary completion: 2028-01-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.